Hager Investment Management Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.4K Hold
260
0.02% 146
2026
Q1
$43.9K Hold
260
0.02% 151
2025
Q4
$43.9K Hold
260
0.02% 146
2025
Q3
$37.5K Hold
260
0.02% 153
2025
Q2
$32.9K Hold
260
0.02% 160
2025
Q1
$33.3K Hold
260
0.02% 152
2024
Q4
$34.4K Buy
+260
New +$36.6K 0.02% 155

Other funds holding IBB

Hager Investment Management Services's IBB Position: Q2 2026 in Review

Hager Investment Management Services held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 260 shares worth $49.4K. The position accounts for 0.02% of the portfolio, ranked #146.

Hager Investment Management Services first reported a position in IBB in Q4 2024 and has held it in 7 quarters since. 223 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Hager Investment Management Services held 260 shares of iShares Biotechnology ETF worth $49.4K as of Q2 2026.
  • Hager Investment Management Services left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.02% of Hager Investment Management Services's portfolio in Q2 2026, its #146 holding.
  • Hager Investment Management Services first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
  • 223 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.